JP Morgan Chase & Co Reiterates “Overweight” Rating for Clovis Oncology, Inc. (CLVS)

Two Sigma Investments, Lp downsized its position by selling 192,854 shares a decrease of 34.7% as of 06/30/2017. The hedge fund run by John Zaro held 5,250 shares of the health care company at the end of 2016Q4, valued at $233,000, down from 14,850 at the end of the previous reported quarter. The share price was last seen 0.31% higher, reaching at $225.55 on August 25, 2017. About 917,524 shares traded.

Clovis Oncology, Inc. has a 1-year low of $22.56 and a 1-year high of $99.45. It has outperformed by 266.01% the S&P500.

Tocqueville Asset Management L.P. increased its stake in Clovis Oncology, Inc. Css Limited Company Il reported 5,832 shares. The Armistice Capital Llc holds 228,000 shares with $7.64 million value, up from 212,000 last quarter. The firm’s market cap is $4.25 billion. The stock rose 6.36% or $6 reaching $100.3 per share. Shares saw a steep decrease in trading volume of 38.48% under the normal average daily volume. LCI Industries (NYSE:DW) has 0.00% since August 28, 2016 and is. It has underperformed by 15.32% the S&P500.

Since March 15, 2017, it had 0 buys, and 3 insider sales for $528,600 activity.

Investors sentiment decreased to 1.03 in 2016 Q4. Its down 0.97, from 2 in 2016Q3. Hsbc Holdg Public Limited Com stated it has 5,475 shares or 0% of all its holdings.

Other hedge funds have also recently made changes to their positions in the company. Natl Bank Of America De invested 0% in Clovis Oncology Inc (NASDAQ:CLVS). 83,014 are owned by Marshall Wace Llp.

Shares of Clovis Oncology (NASDAQ CLVS) opened at 95.00 on Tuesday. Moreover, Td Asset Management has 0% invested in Clovis Oncology Inc (NASDAQ:CLVS) for 17,226 shares. The firm owned 57,125 shares of the biopharmaceutical company’s stock after buying an additional 31,175 shares during the period. Clovis Oncology’s revenue for the quarter was down 32.5% compared to the same quarter a year ago.

Clovis Oncology, Inc. (NASDAQ:CLVS) soared 67.4% year-to-date. 2,215 are owned by Focused Wealth Inc. Creative Planning owns 8,674 shares.

TRADEMARK VIOLATION WARNING: “SG Americas Securities LLC Has $1.81 Million Stake in Clovis Oncology, Inc”. Northern Tru reported 0.01% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS). Mufg Americas accumulated 411 shares. The original version of this piece of content can be read at https://weekherald.com/2017/08/24/clovis-oncology-inc-clvs-shares-bought-by-tocqueville-asset-management-l-p.html. (NASDAQ:CLVS)’s Buy count is 0 and Strong Buy is 6 while the number of analysts recommending Sell and Strong Sell are 0 and 3, respectively. Therefore 72% are positive.

CLVS has been the subject of a number of analyst reports. Stifel Nicolaus maintained it with “Buy” rating and $45 target in Wednesday, September 21 report. Leerink Swann dropped their price objective on shares of Clovis Oncology to $107.00 and set an “outperform” rating for the company in a research note on Friday, August 18th. Piper Jaffray upgraded the stock to “Overweight” rating in Thursday, January 26 report. The stock has “Neutral” rating by JP Morgan on Wednesday, April 13. WallachBeth Capital maintained Clovis Oncology Inc (NASDAQ:CLVS) on Thursday, September 10 with “Buy” rating. On June 20 the company was upgraded to “Buy” from “Neutral” in an announcement from Janney Capital.

More notable recent Clovis Oncology Inc (NASDAQ:CLVS) news were published by: Businesswire.com which released: “Clovis Oncology Announces Second Quarter 2017 Operating Results” on August 02, 2017, also Warriortradingnews.com with their article: “Clovis Oncology, Inc”. Clovis Oncology Inc. now has $3.58B valuation. Driehaus Capital Management LLC purchased a new stake in Clovis Oncology during the first quarter worth about $1,019,000. (NYSE:PANW) by 4,400 shares in the quarter, for a total of 35,151 shares, and has risen its stake in Waste Connections Inc Com. Following the completion of the transaction, the director now directly owns 2,185 shares in the company, valued at $171,762.85.

Investors sentiment decreased to 0.98 in 2016 Q4. Its down 0.97, from 2 in 2016Q3. It improved, as 30 investors sold CLVS shares while 48 reduced holdings. 24 funds opened positions while 64 raised stakes. Ameriprise holds 0.01% or 73,119 shares. Bokf Na stated it has 98,670 shares. 16,125 were reported by Manufacturers Life Ins The. State Board Of Administration Of Florida Retirement has invested 0% in LCI Industries (NYSE:LCII). Partner Fund Ltd Partnership holds 1.6% or 1.28M shares. Alps Advsr reported 2,913 shares. Eulav Asset Mngmt holds 33,400 shares or 0.19% of its portfolio. Passport Ltd Liability Co has 381,814 shares for 0.28% of their portfolio. Nicholas Prns Lp has 0.52% invested in LCI Industries (NYSE:LCII). Citadel Advsrs Lc stated it has 160,443 shares or 0.01% of all its holdings. Amg Natl Bancorp reported 40,810 shares. SunTrust has “Buy” rating and $30 target. Enanta Pharmaceuticals Inc had 13 analyst reports since August 7, 2015 according to SRatingsIntel. Nine analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock.

Leave a Reply

Your email address will not be published. Required fields are marked *